SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 332 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -88.9% | 70 | -87.7% | 0.00% | -87.5% |
| Q1 2022 | $45,000 | -11.8% | 570 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | -48.5% | 570 | -46.7% | 0.01% | -55.6% |
| Q3 2021 | $99,000 | +19.3% | 1,070 | 0.0% | 0.02% | +20.0% |
| Q2 2021 | $83,000 | +3.8% | 1,070 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $80,000 | -18.4% | 1,070 | +85.8% | 0.02% | -28.0% |
| Q4 2020 | $98,000 | +60.7% | 576 | +32.1% | 0.02% | +25.0% |
| Q3 2020 | $61,000 | +60.5% | 436 | +84.7% | 0.02% | +33.3% |
| Q2 2020 | $38,000 | +81.0% | 236 | +11.8% | 0.02% | +50.0% |
| Q1 2020 | $21,000 | +50.0% | 211 | +99.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +75.0% | 106 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $8,000 | -50.0% | 106 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $16,000 | +1500.0% | 106 | +1666.7% | 0.01% | +600.0% |
| Q1 2019 | $1,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |